Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen

NCT00346216 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24081

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: celecoxib
DRUG: Ibuprofen
DRUG: Naproxen

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Collaborators

[object Object]